Terms: = Lung cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
35 results:
1. Metadherin Regulates Inflammatory Breast cancer Invasion and Metastasis.
Ortiz-Soto G; Babilonia-Díaz NS; Lacourt-Ventura MY; Rivera-Rodríguez DM; Quiñones-Rodríguez JI; Colón-Vargas M; Almodóvar-Rivera I; Ferrer-Torres LE; Suárez-Arroyo IJ; Martínez-Montemayor MM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902125
[TBL] [Abstract] [Full Text] [Related]
2. KRAS-Mutant lung cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions.
Karimi N; Moghaddam SJ
Cells; 2023 Feb; 12(5):. PubMed ID: 36899885
[No Abstract] [Full Text] [Related]
3. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features.
Sharifinejad N; Azizi G; Chavoshzadeh Z; Mahdaviani SA; Alan MS; Tavakol M; Sadri H; Nabavi M; Ebrahimi SS; Shirkani A; Vosughi Motlagh A; Safarirad M; Aghamahdi F; Nazari F; Delavari S; Jamee M; Fayyaz F; Samimisedeh P; Matani R; Esmaeili M; Yazdani R; Rezaei N; Abolhassani H
Front Immunol; 2022; 13():1023127. PubMed ID: 36544766
[TBL] [Abstract] [Full Text] [Related]
4. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma.
Shi YX; Zhang WD; Dai PH; Deng J; Tan LH
Sci Rep; 2022 Jun; 12(1):9938. PubMed ID: 35705627
[TBL] [Abstract] [Full Text] [Related]
6. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
[TBL] [Abstract] [Full Text] [Related]
7. Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response.
Wang XR; Jiang ZB; Xu C; Meng WY; Liu P; Zhang YZ; Xie C; Xu JY; Xie YJ; Liang TL; Yan HX; Fan XX; Yao XJ; Wu QB; Leung EL
Pharmacol Res; 2022 May; 179():106198. PubMed ID: 35367343
[TBL] [Abstract] [Full Text] [Related]
8. Pulmonary epithelial-myoepithelial carcinoma (P-EMC) with focal high grade transformation: Molecular and cytologic findings.
Charles R; Murray S; Gray E; Hu J
Diagn Cytopathol; 2022 Jun; 50(6):E156-E162. PubMed ID: 35100487
[TBL] [Abstract] [Full Text] [Related]
9. Loss of TIPE3 reduced the proliferation, survival and migration of lung cancer cells through inactivation of Akt/mTOR, NF-κB, and STAT-3 signaling cascades.
Bordoloi D; Harsha C; Padmavathi G; Banik K; Sailo BL; Roy NK; Girisa S; Thakur KK; Khwairakpam AD; Chinnathambi A; Alahmadi TA; Alharbi SA; Shakibaei M; Kunnumakkara AB
Life Sci; 2022 Mar; 293():120332. PubMed ID: 35041835
[TBL] [Abstract] [Full Text] [Related]
10. JAK2/stat3‑mediated dose‑dependent cytostatic and cytotoxic effects of sesquiterpene lactones from
Keeratichamroen S; Lirdprapamongkol K; Thongnest S; Boonsombat J; Chawengrum P; Sornprachum T; Sirirak J; Verathamjamras C; Ornnork N; Ruchirawat S; Svasti J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738622
[TBL] [Abstract] [Full Text] [Related]
11. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Cardona AF; Jaramillo-Velásquez D; Ruiz-Patiño A; Polo C; Jiménez E; Hakim F; Gómez D; Ramón JF; Cifuentes H; Mejía JA; Salguero F; Ordoñez C; Muñoz Á; Bermúdez S; Useche N; Pineda D; Ricaurte L; Zatarain-Barrón ZL; Rodríguez J; Avila J; Rojas L; Jaller E; Sotelo C; Garcia-Robledo JE; Santoyo N; Rolfo C; Rosell R; Arrieta O
J Neurooncol; 2021 Sep; 154(3):353-364. PubMed ID: 34498213
[TBL] [Abstract] [Full Text] [Related]
13. PIWI‑interacting RNA in cancer: Molecular mechanisms and possible clinical implications (Review).
Yuan C; Qin H; Ponnusamy M; Chen Y; Lin Z
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34328192
[TBL] [Abstract] [Full Text] [Related]
14. EGFR and PDL1: A Match (Not) Made in Heaven-A Real-World Retrospective Analysis of PDL1 Expression in EGFR-Mutated NSCLC.
Batra U; Sharma M; Nathany S; Bansal A; Pasricha S; Jain P; Mehta A; Singh H
Adv Ther; 2021 Apr; 38(4):1791-1800. PubMed ID: 33641057
[TBL] [Abstract] [Full Text] [Related]
15. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.
Alizadeh A; Jebelli A; Baradaran B; Amini M; Oroojalian F; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Gene; 2021 Feb; 769():145224. PubMed ID: 33059027
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression.
Ba MC; Ba Z; Long H; Cui SZ; Gong YF; Yan ZF; Lin KP; Wu YB; Tu YN
Cell Death Dis; 2020 Jan; 11(1):64. PubMed ID: 31988283
[TBL] [Abstract] [Full Text] [Related]
17. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract] [Full Text] [Related]
18. Mechanistic Understanding of Curcumin's Therapeutic Effects in lung cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract] [Full Text] [Related]
19. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (stat3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell lung cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract] [Full Text] [Related]
20. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
Esteves P; Dard L; Brillac A; Hubert C; Sarlak S; Rousseau B; Dumon E; Izotte J; Bonneu M; Lacombe D; Dupuy JW; Amoedo N; Rossignol R
Oncogene; 2020 Jan; 39(3):617-636. PubMed ID: 31527668
[TBL] [Abstract] [Full Text] [Related]
[Next]
